COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. [electronic resource]
Producer: 20071024Description: 253-5 p. digitalISSN:- 0920-9964
- Antipsychotic Agents -- therapeutic use
- Benzodiazepines -- therapeutic use
- Catechol O-Methyltransferase -- genetics
- Genotype
- Humans
- Methionine -- genetics
- Olanzapine
- Pharmacogenetics
- Polymorphism, Genetic -- genetics
- Polymorphism, Single Nucleotide
- Psychiatric Status Rating Scales -- statistics & numerical data
- Schizophrenia -- diagnosis
- Schizophrenic Psychology
- Treatment Outcome
- Valine -- genetics
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.